Young Suk Kim1, Jun Won Kim2, Won Sup Yoon3, Min Kyu Kang4, Ik Jae Lee2, Tae Hyun Kim5, Jin Hee Kim6, Hyung-Sik Lee7, Hee Chul Park8, Hong Seok Jang9, Chul Seung Kay9, Sang Min Yoon10, Mi-Sook Kim11, Jinsil Seong12. 1. Department of Radiation Oncology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea. 2. Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. 3. Department of Radiation Oncology, Ansan Hospital, Korea University Medical Center, Ansan, Korea. 4. Department of Radiation Oncology, Kyungpook National University School of Medicine, Daegu, Korea. 5. Center for Liver Cancer, National Cancer Center, Goyang, Korea. 6. Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea. 7. Department of Radiation Oncology, Dong-A University College of Medicine, Busan, Korea. 8. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 9. Department of Radiation Oncology, The Catholic University of Korea College of Medicine, Seoul, Korea. 10. Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 11. Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea. 12. Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, 120-752, Seodaemun-gu, Seoul, Korea. jsseong@yuhs.ac.
Abstract
PURPOSE: There has been increasing use of external beam radiotherapy for localized treatment of hepatocellular carcinoma (HCC) with both palliative and curative intent. Quality control of target delineation in primary HCC is essential to deliver adequate doses of radiation to the primary tumor while preserving adjacent healthy organs. We analyzed interobserver variability in gross tumor volume (GTV) delineation for HCC. PATIENTS AND METHODS: Twelve radiation oncologists specializing in liver malignancy participated in a multi-institutional contouring dummy-run study of nine HCC cases and independently delineated GTV on the same set of provided computed tomography images. Quantitative analysis was performed using an expectation maximization algorithm for simultaneous truth and performance level estimation (STAPLE) with kappa statistics calculating agreement between physicians. To quantify the interobserver variability of GTV delineations, the ratio of the actual delineated volume to the estimated consensus volume (STAPLE), the ratio of the common and encompassing volumes, and the coefficient of variation were calculated. RESULTS: The median kappa agreement level was 0.71 (range 0.28-0.86). The ratio of the actual delineated volume to the estimated consensus volume ranged from 0.19 to 1.93 (median 0.94) for all cases. The ratio of the common and encompassing volumes ranged from 0.001 to 0.56 (median 0.25). The coefficient of variation for GTV delineation ranged from 8 to 57 % (median 26 %). CONCLUSION: The interobserver variability in target delineation of HCC GTV in this study is noteworthy. Multi-institution studies involving radiotherapy for HCC require appropriate quality assurance programs for target delineation.
PURPOSE: There has been increasing use of external beam radiotherapy for localized treatment of hepatocellular carcinoma (HCC) with both palliative and curative intent. Quality control of target delineation in primary HCC is essential to deliver adequate doses of radiation to the primary tumor while preserving adjacent healthy organs. We analyzed interobserver variability in gross tumor volume (GTV) delineation for HCC. PATIENTS AND METHODS: Twelve radiation oncologists specializing in liver malignancy participated in a multi-institutional contouring dummy-run study of nine HCC cases and independently delineated GTV on the same set of provided computed tomography images. Quantitative analysis was performed using an expectation maximization algorithm for simultaneous truth and performance level estimation (STAPLE) with kappa statistics calculating agreement between physicians. To quantify the interobserver variability of GTV delineations, the ratio of the actual delineated volume to the estimated consensus volume (STAPLE), the ratio of the common and encompassing volumes, and the coefficient of variation were calculated. RESULTS: The median kappa agreement level was 0.71 (range 0.28-0.86). The ratio of the actual delineated volume to the estimated consensus volume ranged from 0.19 to 1.93 (median 0.94) for all cases. The ratio of the common and encompassing volumes ranged from 0.001 to 0.56 (median 0.25). The coefficient of variation for GTV delineation ranged from 8 to 57 % (median 26 %). CONCLUSION: The interobserver variability in target delineation of HCC GTV in this study is noteworthy. Multi-institution studies involving radiotherapy for HCC require appropriate quality assurance programs for target delineation.
Entities:
Keywords:
Chemoembolization; Organs at risk; Quality assurance; Radiofrequency ablation; Radiotherapy
Authors: Geert M Villeirs; Koen Van Vaerenbergh; Luc Vakaet; Samuel Bral; Filip Claus; Wilfried J De Neve; Koenraad L Verstraete; Gert O De Meerleer Journal: Strahlenther Onkol Date: 2005-07 Impact factor: 3.621
Authors: Theodore S Hong; Walter R Bosch; Sunil Krishnan; Tae K Kim; Harvey J Mamon; Paul Shyn; Edgar Ben-Josef; Jinsil Seong; Michael G Haddock; Jason C Cheng; Mary U Feng; Kevin L Stephans; David Roberge; Christopher Crane; Laura A Dawson Journal: Int J Radiat Oncol Biol Phys Date: 2014-07-15 Impact factor: 7.038
Authors: Theodore S Hong; Thomas F DeLaney; Harvey J Mamon; Christopher G Willett; Beow Y Yeap; Andrzej Niemierko; John A Wolfgang; Hsiao-Ming Lu; Judith Adams; Elizabeth A Weyman; Ronald S Arellano; Lawrence S Blaszkowsky; Jill N Allen; Kenneth K Tanabe; David P Ryan; Andrew X Zhu Journal: Pract Radiat Oncol Date: 2013-11-22
Authors: Michael Oertel; Martina Schmitz; Jan Carl Becker; Hans Theodor Eich; Anna Schober Journal: Strahlenther Onkol Date: 2019-07-15 Impact factor: 3.621
Authors: E Gkika; S Tanadini-Lang; S Kirste; P A Holzner; H P Neeff; H C Rischke; T Reese; F Lohaus; M N Duma; K Dieckmann; R Semrau; M Stockinger; D Imhoff; N Kremers; M F Häfner; N Andratschke; U Nestle; A L Grosu; M Guckenberger; T B Brunner Journal: Strahlenther Onkol Date: 2017-07-10 Impact factor: 3.621
Authors: Mario Amrehn; Stefan Steidl; Reinier Kortekaas; Maddalena Strumia; Markus Weingarten; Markus Kowarschik; Andreas Maier Journal: Int J Biomed Imaging Date: 2019-09-05
Authors: Ingrid Kristensen; Kristina Nilsson; Måns Agrup; Karin Belfrage; Anna Embring; Hedda Haugen; Anna-Maja Svärd; Tommy Knöös; Per Nilsson Journal: Tech Innov Patient Support Radiat Oncol Date: 2017-11-04